Dayal Institute of Medical Sciences Withdraws Complaint Against Chandan Healthcare Limited Following Amicable Settlement
Chandan Healthcare Limited has announced the complete withdrawal of a complaint previously filed by Dayal Institute of Medical Sciences Limited regarding alleged financial irregularities in the affairs of the company and its group entities. The withdrawal follows an amicable settlement reached between both parties.Dayal Institute of Medical Sciences Limited, which was formerly known as Chandan Institute of Medical Sciences Limited, confirmed that all disputes, differences, and claims related to the complaint have been settled after a process involving balance confirmation and account reconciliation between the parties.
The original complaint had been filed on May 18, 2026, before various statutory and regulatory authorities concerning financial irregularities in relation to Chandan Healthcare Limited (NSE Symbol: CHANDAN) and other entities of the Chandan Group.
Following the successful settlement, Dayal Institute of Medical Sciences Limited has formally withdrawn the entire complaint and all prayers contained therein against Chandan Healthcare Limited, its directors, officers, promoters, group companies, and connected individuals. The institute requested that the matter be treated as closed.
Chandan Healthcare Limited stated that the withdrawal of the complaint and the settlement of the dispute remove uncertainty arising from the earlier allegations. The company added that the concluded matter will have no adverse impact on its operations or financial position.
CHANDAN Stock Price Movement
Chandan Healthcare Limited shares edged higher today, settling at ₹239.10 after gaining 0.38%. The stock traded within an intraday range of ₹238.7 to ₹242, with a volume of 12,000 shares recorded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.